Sheryl Trueman serves as the Director of Clinical Pharmacology at Jazz Pharmaceuticals, leveraging a strong background in pharmacokinetics from her time at AbbVie. She holds a PhD in Pharmaceutical Science from the University at Buffalo, specializing in clinical drug development and modeling.
Rooted in a passion for medical research, her academic background includes conducting original studies on pancreatic cancer. She also has experience in scientific education, having served as a teaching and graduate assistant responsible for tutoring and lecturing university students.
Unique fact: Sheryl conducted independent thesis research on the role of stromal modulators in pancreatic cancer.